Effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on serum levels of sICAM-1, sIL-2R and clinical parameters of asthma in children;Wpływ acetonidu triamcinolonu, montelukastu, nedokromilu sodu, formoterolu na stȩżenia sICAM-1 i sIL-2R w surowicy oraz przebieg kliniczny astmy u dzieci

Polski Merkuriusz Lekarski

Volumn 12, Issue 68, 2002, Pages 99-103

  Stelmach, Iwona ^a   Jerzyńska, Joanna ^a   Majak, Pawel ^a   Grzelewski, Tomasz ^a   Górski, Pawel ^a   Stelmach, Wlodzimierz ^a   Kuna, Piotr ^a  

^a Samodzielny Oddzial Klin Interny   (Poland)

Author keywords

Childhood asthma; Inflammation; sICAM 1; sIL 2R

Indexed keywords

FORMOTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MONTELUKAST; NEDOCROMIL SODIUM; PLACEBO; TRIAMCINOLONE ACETONIDE;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL;

ACETATES; ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; CHILD; DOUBLE-BLIND METHOD; ETHANOLAMINES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; NEDOCROMIL; QUINOLINES; RECEPTORS, INTERLEUKIN; TRIAMCINOLONE ACETONIDE;

EID: 0036119852     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Asthma controller therapy: Role of antileukotrienes, a new therapeutic class
2. A placebo-controlled, dose-ranging study of montelukast, a cysteiny I leukotriene-receptor antagonist, Montelukast Asthma Study Group
3. Pripheral blood markers: Evaluation and inflammation in asthma
4. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids
5. Determination of Histamine PC20
6. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
7. Nedocromil sodium and airway inflammation in vivo and in vitro
8. The effect of montelukast, a cysteinyl leukotriene receptor antagonist, an allergen-induced airway responses and sputum cell counts in asthma
9. Treatment of asthma with drugs modifying the leukotriene pathway
10. Soluble intercellular adhesion molecule-1 in sera of children with bronchial asthma exacerbation
11. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation
12. Measuring quality of life in children with asthma
13. A long-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma
14. Serum concentration of soluble interleukin 2 receptors in asthma. Correlation with disease activity
15. Leukotriene-receptor antagonists
16. Effects of treatment with formoterol on bronchoprotection against metacholine
17. Sodium cromoglycate inhibits antigen-induced cytokine production by peripheral blood mononuclear cells from atopic asthmatics in vitro
18. Circulating adhesion molecules in asthma
19. Serum levels of soluble interleukin-2 receptor in asthma patients
20. Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma
21. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma
22. A mechanism forthe anti-inflammatory effect of nedocromil; inhibition of both adhesion molecule expression on eosinophils and endothelial cells, and eosinophil chemotactic activities
23. Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: Inflammatory cells, lymphocyte subsets and soluble markers compared
24. Formoterol used on demand improves quality of life in patients with asthma
25. Comparison of salmeterol with placebo in mild asthma: Effect on peripheral blood phagocyte function and cytokine levels
26. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics
27. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts
28. Expression of serum IL-2, IL-2R, and CD8 levels during hyposensitization in house-dust-sensitive asthmatics